Home › Aldermeesklierkanker › Minnesota › Rochester
Aldermeesklierkanker klinische studies in Rochester, MN
22 studies voor Aldermeesklierkanker zoeken deelnemers op locaties in en rond Rochester (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma
RekruterenFase 2
- Mayo Clinic in Rochester, Rochester
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
RekruterenFase 1
- Mayo Clinic Rochester, Rochester
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RekruterenObservatieonderzoek
- Mayo Clinic Rochester, Rochester
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
RekruterenFase 2/3
- Mayo Clinic Cancer Center Outpatient Pharmacy, Rochester
- Mayo Clinic, Rochester
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
RekruterenFase 3
- Mayo Clinic Cancer Center, Rochester
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
RekruterenFase 1/2
- Mayo Clinic, Rochester
Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts
RekruterenObservatieonderzoek
- Mayo Clinic in Rochester, Rochester
A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
RekruterenFase 2
- Mayo Clinic Rochester, Rochester
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
RekruterenFase 2
- Local Institution - 0129, Rochester
- Local Institution - 0174, Rochester
- Local Institution - 0181, Rochester
Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis
RekruterenFase 2
- Mayo Clinic in Rochester, Rochester
CREO - Microwave Ablation Feasibility Study
Rekruteren
- Mayo Clinic Rochester, Rochester
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
RekruterenObservatieonderzoek
- Mayo Clinic in Rochester, Rochester
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
RekruterenFase 2
- Mayo Clinical Rochester, Rochester
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
RekruterenFase 1
- Mayo Clinic, Rochester
Investigational Scan (68Ga-FAPI-46 PET/CT) for Imaging of Cancer-Associated Fibroblasts for Localized Pancreatic Ductal Adenocarcinoma
RekruterenFase 2
- Mayo Clinic in Rochester, Rochester
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
RekruterenFase 1/2
- Mayo Clinic Rochester, Rochester
A Prospective Registry for Patients at High-Risk for Pancreatic Cancer
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Mayo Clinic in Rochester, Rochester
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
RekruterenObservatieonderzoek
- Mayo Clinic in Rochester, Rochester
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
RekruterenFase 2
- Ohio State University Telemedicine, Rochester
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Mayo Clinic, Rochester
JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration
RekruterenFase 1/2
- Mayo Clinic, Rochester
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
RekruterenFase 1
- Exelixis Clinical Site #14, Rochester
Aldermeesklierkanker studies in andere steden
- Houston, TX61 studies
- New York City, NY60 studies
- Boston, MA43 studies
- Nashville, TN39 studies
- Los Angeles, CA35 studies
- St. Louis, MO33 studies
- Arlington, VA33 studies
- Baltimore, MD31 studies
- San Antonio, TX31 studies
- Philadelphia, PA26 studies
- Tampa, FL26 studies
- Durham, NC24 studies
Andere studies in Rochester
- Borstkanker42 studies
- Niet-kleincellige longkanker37 studies
- Metastatische kanker31 studies
- Kanker (alle vormen)30 studies
- Eierstokkanker29 studies
- Colorectale kanker29 studies
- Multipel myeloom24 studies
- Hartfalen22 studies
- Prostaatkanker22 studies
- Endometriumkanker20 studies
- Longkanker20 studies
- Chronische lymfatische leukemie18 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.